Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretroviral Therapy | Zendy

Rapeepan Suaysod | Zendy; Nicole NgoGiangHuong | Zendy; Nicolas Salvadori | Zendy; Tim R. Cressey | Zendy; Suparat Kanjanavanit | Zendy; Pornchai Techakunakorn | Zendy; Sawitree Krikajornkitti | Zendy; Sakulrat Srirojana | Zendy; Laddawan Laomanit | Zendy; Suwalai Chalermpantmetagul | Zendy; Marc Lallemant | Zendy; Sophie Le Cœur | Zendy; Kenneth McIntosh | Zendy; Patrinee Traisathit | Zendy; Gonzague Jourdain | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretroviral Therapy

Author(s) -

Rapeepan Suaysod,

Nicole NgoGiangHuong,

Nicolas Salvadori,

Tim R. Cressey,

Suparat Kanjanavanit,

Pornchai Techakunakorn,

Sawitree Krikajornkitti,

Sakulrat Srirojana,

Laddawan Laomanit,

Suwalai Chalermpantmetagul,

Marc Lallemant,

Sophie Le Cœur,

Kenneth McIntosh,

Patrinee Traisathit,

Gonzague Jourdain

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ271

Subject(s) - medicine , antiretroviral therapy , protease inhibitor (pharmacology) , regimen , second line , human immunodeficiency virus (hiv) , sida , virology , first line , viral load , intensive care medicine , immunology , viral disease

Human immunodeficiency virus (HIV)-infected children failing second-line antiretroviral therapy (ART) have no access to third-line antiretroviral drugs in many resource-limited settings. It is important to identify risk factors for second-line regimen failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research